Position in SCLX
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$150,554
-$98,862 QoQ
Shares Held
36,305
+10.6% QoQ
Ownership
0.427%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2023
8 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in SCLX Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026XTX Topco Ltd holds $46,000,026 across 13 Drug Manufacturers - General names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | PFE |
Pfizer Inc
|
834,735 | $20,100,418 | |
| 2 | GILD |
Gilead Sciences, Inc.
|
68,150 | $8,610,071 | |
| 3 | LLY |
ELI LILLY & Co
|
6,991 | $8,385,215 | |
| 4 | NVO |
Novo Nordisk A S
|
48,420 | $2,321,254 | |
| 5 | GSK |
GSK plc
|
35,304 | $1,850,635 | |
| 6 | NVS |
Novartis AG
|
11,248 | $1,762,786 | |
| 7 | JNJ |
Johnson & Johnson
|
5,135 | $1,304,135 | |
| 8 | BIIB |
Biogen Inc.
|
3,239 | $699,818 |
All Filings in SCLX
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $150,554 | 22,606 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $249,416 | 20,444 | Shares | Defined | 2026-02-17 | |
| 2024-09-30 | $79,859 | 86,335 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $203,481 | 105,431 | Shares | Defined | 2024-08-12 | |
| 2024-03-31 | $39,784 | 25,022 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $51,452 | 25,222 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $52,309 | 37,364 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $60,122 | 10,794 | Shares | Defined | 2023-08-14 | |
| No filing history on record for this holder in this stock. | ||||||